Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 70 of 1,261
  1. US 12186436

    Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  2. US 12187731

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  3. US 12187694

    SLC26A3 inhibitors and use thereof

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  4. US 12186367

    Isoform Nell-1 peptide

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  5. US 12188949

    Noninvasive method to quantify kidney function and functional decline

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  6. US 12185909

    System and method for cleansing segments of a luminal network

    Covidien LP Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  7. US 12188069

    Biocatalyst and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  8. US 12188058

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  9. US 12186428

    Combination taxoid nanoemulsion with immunotherapy in cancer

    Northwestern University Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  10. US 12186406

    Materials and methods for treatment of hereditary haemochromatosis

    CRISPR THERAPEUTICS AG Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  11. US 12187746

    C26-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  12. US 12186368

    Compositions and methods for treatment of protease mediated disease

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  13. US 12186375

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  14. US 12188926

    Stimuli responsive microsphere composites

    SOUTH DAKOTA BOARD OF REGENTS Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  15. US 12188948

    Metabolite biomarkers for diseases associated with the contact activation system

    Takeda Pharmaceutical Company Limited Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  16. US 12186369

    Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  17. US 12187679

    Hydroxylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  18. US 12188072

    Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates

    Northwestern University Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  19. US 12187848

    Compositions and methods for cellular delivery

    The Regents of the University of California Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  20. US 12188048

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  21. US 12186282

    Treatment of 22Q11.2 deletion syndrome with cannabidiol

    Harmony Biosciences Management, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  22. US 12187815

    Anti-inflammatory nanofibers

    Northwestern University Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  23. US 12188017

    Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin

    Arrowhead Pharmaceuticals, Inc. Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted
  24. US 12186314

    Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.